ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentSchlierenProxima Bio GmbH
Proxima Bio GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Proxima Bio GmbH develops AI-based platforms for drug discovery and the analysis of protein interactions. The company focuses on structure prediction, molecular design, and data platforms for proximity-modulation therapeutics.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical IndustrySoftware Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
No score yet

Proxima Bio GmbH

✓ Offered4
AI-Enabled Drug Discovery and Molecular Design
Drug discovery with an integrated model for structure prediction, de novo generation, protein and small-molecule design, docking, inpainting, and lead optimization.
Structural Proteomics and Cross-Linking Mass Spectrometry
Structural data platform based on XLMS for measuring interatomic distances, generating structural restraints, and reconstructing complex protein structures.
Protein Structure Prediction and Molecular Docking
Structure prediction for monomers and complexes, including protein-protein, protein-ligand, and ProMod-bound systems, plus docking-based use of available structures.
Molecular Glue and ProMod Development
Development of molecular glue and proximity-modulation therapeutics, including ternary complexes, PROTACs, and other protein-recruiting therapies.
Trust & reputation

ranQ Trust Score of Proxima Bio GmbH

Trust Score

No score yet

x

A published score requires a data basis of at least 50% and data from at least two criteria groups other than identity. Missing evidence: Review quality, Review volume, Review recency, Website authority, Media authority

Data basis 50% · As of October 2026

Proxima Bio GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Proxima Bio GmbH scores 46.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.0.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Proxima Bio GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Proxima Bio GmbH has no value in the Visibility area of the ranQ Trust Score because no data is available. The area carries 8% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Website authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%

The data basis is 50%, below the threshold at which ranQ publishes a score. Evidence is missing for: Review quality, Review volume, Review recency, Website authority, Media authority. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Proxima Bio GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Proxima Bio GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Proxima Bio GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Proxima Bio GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Zürcherstrasse 39d
8952 Schlieren

At a glance

Legal form
Limited Liability Company
UID
CHE-468.651.098
Founded
2026 · 0 years
Last commercial register change
June 24, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    BA
    BiognoSYS AG
    Schlieren
    AA
    Athebio AG
    Schlieren
    MA
    Mabylon AG
    Schlieren
    IB
    InterAx Biotech AG
    Schlieren
    NA
    Neurimmune AG
    Schlieren
    IG
    inSili.com GmbH
    Zurich
    BI
    Bruker Invest AG
    Fällanden
    CR
    Charles River Laboratories Switzerland AG
    Hettlingen